Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency

Journal: Journal of Clinical Investigation

Published: 2020-09-28

DOI: 10.1172/jci98882

Affiliations: 22

Authors: 37

Go to article
Institutions Share
Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore 0.38
SingHealth Translational Immunology Institute (TII), Singapore 0.12
KK Women's and Children's Hospital (KKH), Singapore 0.12
Duke-NUS Graduate Medical School Singapore, Singapore 0.12
Singapore Immunology Network (SIgN), A*STAR, Singapore 0.08
NUS Department of Microbiology and Immunology (MBIO), Singapore 0.05
NUS Immunology Programme, Singapore 0.04
NUS Department of Pathology, Singapore 0.02
National University of Singapore (NUS), Singapore 0.01
NUS Cancer Science Institute of Singapore (CSI), Singapore 0.01
NUS Department of Physiology, Singapore 0.01
Laboratory of NF-κB Signaling, IMCB, Singapore 0.01
Centre for Cancer Biology, Australia 0.01
Faculty of Health Sciences (FHS), UM, China 0.01
School of Medicine, KU, Turkey 0.01
NUS Department of Paediatrics, Singapore 0.01
Institute of Medical Biology (IMB), A*STAR, Singapore 0.01
Institute of Biomedical Studies, Baylor University, United States of America (USA) 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER